Sabina P W Guenther, Rayan Cheaban, Lisa Hoepner, Nicole Weinrautner, Thomas Kirschning, Riad Al-Khalil, Frank Bruenger, Maria R Serrano, Iris Barndt, Marcus Wiemer, Jost Niedermeyer, Markus Rudloff, Sven Helms, René Schramm, Jan F Gummert
Extracorporeal membrane oxygenation (ECMO) is increasingly used in COVID-19-related pulmonary failure and the number of patients recovering from COVID-19 is growing. Here, we assess survival and recovery 6 months after ECMO for COVID-19. From April 2020 to September 2021, n = 60 (60.5 [51.0-65.0] years, 23.3% female) were treated with venovenous/venoarterial ECMO for COVID-19. 41.7% were weaned off ECMO, survival-to-discharge was 40.0% (n = 24). Age (63.0 [60.0-66.8] vs. 55.0 [43.8-60.0] years, p < 0.001), vasoactive support (97...
June 1, 2023: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs